John McDonald

Author PubWeight™ 54.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pre-procedural fasting for coronary interventions: is it time to change practice? Heart 2014 2.61
2 The relative roles in vivo of Saccharomyces cerevisiae Pol eta, Pol zeta, Rev1 protein and Pol32 in the bypass and mutation induction of an abasic site, T-T (6-4) photoadduct and T-T cis-syn cyclobutane dimer. Genetics 2004 2.39
3 Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS One 2012 2.23
4 Sensory integration and the perceptual experience of persons with autism. J Autism Dev Disord 2006 1.95
5 CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 2005 1.72
6 A review of mathematical models used to determine sperm donor limits for infertility treatment. Fertil Steril 2007 1.50
7 [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. Br J Pharmacol 2002 1.14
8 Lack of "immunological fitness" during fasting in metabolically challenged animals. J Lipid Res 2012 1.08
9 Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 2007 1.05
10 Exonization of the LTR transposable elements in human genome. BMC Genomics 2007 0.99
11 The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties. J Biol Chem 2003 0.98
12 Inflammation in the uterus induces phosphorylated extracellular signal-regulated kinase and substance P immunoreactivity in dorsal root ganglia neurons innervating both uterus and colon in rats. J Neurosci Res 2008 0.98
13 Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies. J Pharmacol Exp Ther 2007 0.95
14 Transcriptional profiling of initial differentiation events in human embryonic stem cells. Biochem Biophys Res Commun 2004 0.93
15 Are hygiene standards useful in assessing infection risk? Am J Infect Control 2008 0.93
16 Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. Eur J Pharmacol 2009 0.92
17 Modeling the atmospheric transport and deposition of PCDD/F to the Great Lakes. Environ Sci Technol 2002 0.91
18 Materials by Design: Merging Proteins and Music. Nano Today 2012 0.91
19 A force plate study of avian gait. J Biomech 2006 0.87
20 Neuronal activity promotes myelination via a cAMP pathway. Glia 2013 0.87
21 Human peripheral blood mononuclear cells express nociceptin/orphanin FQ, but not mu, delta, or kappa opioid receptors. Anesth Analg 2007 0.87
22 Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist. Bioorg Med Chem 2005 0.86
23 Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study. Clin Cardiol 2007 0.86
24 Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. Bioorg Med Chem 2009 0.85
25 Predictors of support service use by rural and regional men with cancer. Aust J Rural Health 2011 0.84
26 Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: in vitro and in vivo studies. Peptides 2006 0.84
27 Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom 2008 0.84
28 Modeling the atmospheric transport and deposition of mercury to the Great Lakes. Environ Res 2004 0.84
29 Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids. Bioorg Med Chem 2007 0.84
30 The same dorsal root ganglion neurons innervate uterus and colon in the rat. Neuroreport 2007 0.84
31 [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor. J Pharmacol Exp Ther 2004 0.83
32 Infant feeding practices and chronic child malnutrition in the Indian states of Karnataka and Uttar Pradesh. Econ Hum Biol 2004 0.83
33 Electrophysiological evidence of multitasking impairment of attentional deployment reflects target-specific processing, not distractor inhibition. Int J Psychophysiol 2012 0.83
34 The Nociceptin/Orphanin FQ system is modulated in patients admitted to ICU with sepsis and after cardiopulmonary bypass. PLoS One 2013 0.82
35 Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors. Naunyn Schmiedebergs Arch Pharmacol 2008 0.82
36 Sotalol induced QT prolongation and torsades de pointes. BMJ Case Rep 2009 0.82
37 Neuromuscular junction in a microfluidic device. Conf Proc IEEE Eng Med Biol Soc 2013 0.82
38 Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells. Mol Endocrinol 2009 0.81
39 Anticancer properties of 2-piperidyl analogues of the natural indole phytoalexin 1-methoxyspirobrassinol. Chemotherapy 2008 0.81
40 Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity. Naunyn Schmiedebergs Arch Pharmacol 2006 0.80
41 A comparison of the radial and the femoral approaches in primary or rescue percutaneous coronary intervention for acute myocardial infarction in the elderly. Acute Card Care 2007 0.80
42 Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives. Bioorg Med Chem Lett 2004 0.79
43 Teenage births and final adult height of mothers in India, 1998-1999. J Biosoc Sci 2005 0.79
44 Functional electrical stimulation in spinal cord injury:: from theory to practice. Top Spinal Cord Inj Rehabil 2012 0.79
45 The lateral thoracic nerve and the cutaneous maximus muscle--a novel in vivo model system for nerve degeneration and regeneration studies. Exp Neurol 2012 0.78
46 Pharmacological profile and antiparkinsonian properties of the novel nociceptin/orphanin FQ receptor antagonist 1-[1-cyclooctylmethyl-5-(1-hydroxy-1-methyl-ethyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-3-ethyl-1,3-dihydro-benzoimidazol-2-one (GF-4). Peptides 2010 0.78
47 Layer-by-layer nanocoating of lignocellulose fibers for enhanced paper properties. J Nanosci Nanotechnol 2006 0.78
48 The invisible contract: shifting care from the hospital to the home. Aust Health Rev 2007 0.77
49 Rectovaginal Staphylococcus aureus colonization: is it a neonatal threat? Am J Perinatol 2011 0.77
50 N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands. J Med Chem 2005 0.76
51 Desensitisation of native and recombinant human urotensin-II receptors. Naunyn Schmiedebergs Arch Pharmacol 2009 0.76
52 Gene transfection enhanced by ultrasound exposure combined with drug treatment guided by gene chip analysis. Int J Hyperthermia 2012 0.76
53 Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes. Brain Res 2004 0.75
54 Radial artery pseudoaneurysm following coronary angiography in two octogenarians. Exp Clin Cardiol 2012 0.75
55 Single-shot speckle reduction in numerical reconstruction of digitally recorded holograms: comment. Opt Lett 2015 0.75
56 An alternative to climate change for explaining species loss in Thoreau's woods. Proc Natl Acad Sci U S A 2009 0.75
57 Measurement of family health teams is underdeveloped. CMAJ 2011 0.75
58 Development of a wearable motion capture suit and virtual reality biofeedback system for the instruction and analysis of sports rehabilitation exercises. Conf Proc IEEE Eng Med Biol Soc 2007 0.75
59 Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. Peptides 2009 0.75
60 Design of a short electro-optic modulator based on SiGe HBT structure. Opt Express 2010 0.75
61 Levels of soluble human leukocyte antigen class 1 are increased in Graves' disease and toxic multinodular goiter and correlate with the levels of triiodothyronine. Thyroid 2002 0.75
62 Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe? J Ren Care 2012 0.75
63 Active Suppression in Video-Game Players: An ERP Study. J Vis 2015 0.75
64 The relationship between geographic remoteness and intentions to use a telephone support service among Australian men following radical prostatectomy. Psychooncology 2014 0.75
65 How should I treat a patient with giant left main coronary artery aneurysm without associated stenosis? EuroIntervention 2016 0.75
66 Liver transplantation. Postgrad Med 1995 0.75
67 Elementary school-age children's capacity to choose positive diagnostic and negative diagnostic tests. Child Dev 2002 0.75